Long Reads: Big Pharma's Toxic Record w/ Nick...

Stuart Schrader, author of Blue Power, explains how the political heft of cops allows them to get away with murder. Angela Jones, author of Sex in Public, looks at the social and political factors shaping our sexual lives. Behind the News, hosted by Doug Henwood, covers the world ...  Show more

Elon Musk became the world’s first trillionaire last week after the record-breaking IPO of his company SpaceX. Musk presents the firm’s economic take off as the necessary means to a wider end for humanity, to become a multi-planetary species. “That’s what SpaceX is all about,” Mu ...  Show more

Nick Dearden has been an economic justice campaigner for over 20 years, and his attention was on the pharmaceutical industry when Covid-19 hit. But as the world began to sing the praises of pharmaceutical companies, Nick saw an unprecedented PR coup. Giant corporations capitalise ...  Show more

For decades, drugmakers have argued that patents are critical to bringing new drugs to the market. But in 2004, when a promising H.I.V. treatment emerged, Gilead Sciences decided to slow-walk its release to maximize profit on the company’s existing patents.

Rebecca Robbi ...

John Green recently made a video asking Johnson & Johnson not to extend their patent on a tuberculosis drug, which would keep it exclusive and expensive. Dr. Sydnee and Justin talk about how drug patents work, the recent (good) update about bedaquiline specifically, and the ne ...

The second of two episodes this week, taking a deep dive into the pharmaceutical industry.

Big drug companies have won plaudits for their work producing Covid vaccines within a year of the start of the pandemic. How much money are they making from them? And why are vacci ...